Bernstein analyst Lee Hambright raised the firm’s price target on Stryker (SYK) to $450 from $440 and keeps an Outperform rating on the shares. The firm cites a strong Q1, as revenue of $5.9B grew 10.1% organic and beat consensus by 3%. Performance was healthy across regions and segments.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker’s Strong Performance and Growth Potential Justify Buy Rating
- Stryker Corp’s Earnings Call Highlights Robust Growth
- Stryker price target raised to $456 from $405 at Roth Capital
- Stryker’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Stryker’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating